Annual Current Liabilities
$7.22 M
-$1.48 M-17.02%
December 31, 2023
Summary
- As of February 8, 2025, APVO annual total current liabilities is $7.22 million, with the most recent change of -$1.48 million (-17.02%) on December 31, 2023.
- During the last 3 years, APVO annual current liabilities has fallen by -$7.32 million (-50.31%).
- APVO annual current liabilities is now -81.11% below its all-time high of $38.24 million, reached on December 31, 2019.
Performance
APVO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$5.88 M
+$463.00 K+8.54%
September 30, 2024
Summary
- As of February 8, 2025, APVO quarterly total current liabilities is $5.88 million, with the most recent change of +$463.00 thousand (+8.54%) on September 30, 2024.
- Over the past year, APVO quarterly current liabilities has dropped by -$1.34 million (-18.58%).
- APVO quarterly current liabilities is now -84.62% below its all-time high of $38.24 million, reached on December 31, 2019.
Performance
APVO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
APVO Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.0% | -18.6% |
| 3 y3 years | -50.3% | -18.6% |
| 5 y5 years | -59.0% | -84.6% |
APVO Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.2% | at low | -83.1% | +8.5% |
| 5 y | 5-year | -81.1% | at low | -84.6% | +8.5% |
| alltime | all time | -81.1% | at low | -84.6% | +8.5% |
Aptevo Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.88 M(+8.5%) |
| Jun 2024 | - | $5.42 M(-14.0%) |
| Mar 2024 | - | $6.30 M(-12.8%) |
| Dec 2023 | $7.22 M(-17.0%) | $7.22 M(+5.7%) |
| Sep 2023 | - | $6.84 M(-1.1%) |
| Jun 2023 | - | $6.91 M(+19.2%) |
| Mar 2023 | - | $5.80 M(-33.4%) |
| Dec 2022 | $8.71 M(-75.0%) | $8.71 M(+11.8%) |
| Sep 2022 | - | $7.79 M(+11.2%) |
| Jun 2022 | - | $7.00 M(-70.6%) |
| Mar 2022 | - | $23.86 M(-31.4%) |
| Dec 2021 | $34.76 M(+139.1%) | $34.76 M(+7.3%) |
| Sep 2021 | - | $32.38 M(+4.9%) |
| Jun 2021 | - | $30.86 M(+5.2%) |
| Mar 2021 | - | $29.34 M(+101.8%) |
| Dec 2020 | $14.54 M | $14.54 M(+96.0%) |
| Sep 2020 | - | $7.42 M(+5.9%) |
| Jun 2020 | - | $7.00 M(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $6.99 M(-81.7%) |
| Dec 2019 | $38.24 M(+117.1%) | $38.24 M(+2.6%) |
| Sep 2019 | - | $37.25 M(+124.4%) |
| Jun 2019 | - | $16.60 M(-9.3%) |
| Mar 2019 | - | $18.29 M(+3.9%) |
| Dec 2018 | $17.61 M(-4.9%) | $17.61 M(+14.0%) |
| Sep 2018 | - | $15.44 M(-14.7%) |
| Jun 2018 | - | $18.10 M(+4.8%) |
| Mar 2018 | - | $17.27 M(-6.7%) |
| Dec 2017 | $18.51 M(-5.3%) | $18.51 M(+24.5%) |
| Sep 2017 | - | $14.87 M(+25.1%) |
| Jun 2017 | - | $11.88 M(-17.8%) |
| Mar 2017 | - | $14.46 M(-26.0%) |
| Dec 2016 | $19.54 M(-2.0%) | $19.54 M(+28.3%) |
| Sep 2016 | - | $15.23 M(-10.5%) |
| Jun 2016 | - | $17.03 M(-8.9%) |
| Mar 2016 | - | $18.69 M(-6.3%) |
| Dec 2015 | $19.94 M(+0.5%) | $19.94 M |
| Dec 2014 | $19.84 M | - |
FAQ
- What is Aptevo Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Aptevo Therapeutics?
- What is Aptevo Therapeutics annual current liabilities year-on-year change?
- What is Aptevo Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly current liabilities year-on-year change?
What is Aptevo Therapeutics annual total current liabilities?
The current annual current liabilities of APVO is $7.22 M
What is the all time high annual current liabilities for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual total current liabilities is $38.24 M
What is Aptevo Therapeutics annual current liabilities year-on-year change?
Over the past year, APVO annual total current liabilities has changed by -$1.48 M (-17.02%)
What is Aptevo Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of APVO is $5.88 M
What is the all time high quarterly current liabilities for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly total current liabilities is $38.24 M
What is Aptevo Therapeutics quarterly current liabilities year-on-year change?
Over the past year, APVO quarterly total current liabilities has changed by -$1.34 M (-18.58%)